Connecticut 2022 2022 Regular Session

Connecticut Senate Bill SB00342 Introduced / Fiscal Note

Filed 03/30/2022

                    OFFICE OF FISCAL ANALYSIS 
Legislative Office Building, Room 5200 
Hartford, CT 06106  (860) 240-0200 
http://www.cga.ct.gov/ofa 
sSB-342 
AN ACT CONCERNING FEDERAL REIMBURSEMENTS FOR 
CERTAIN PHARMACEUTICAL PURCHASES.  
 
Primary Analyst: LD 	3/28/22 
Contributing Analyst(s):    
 
 
 
 
OFA Fiscal Note 
 
State Impact: 
Agency Affected Fund-Effect FY 23 $ FY 24 $ 
Resources of the General Fund GF - Revenue 
Loss 
$337,000 $337,000 
Department of Veterans' Affairs IGWF - Revenue 
Gain 
$337,000 $337,000 
Note: IGWF = Institutional General Welfare Fund; GF = General Fund 
  
Municipal Impact: None  
Explanation 
The bill results in a General Fund revenue loss of approximately 
$337,000 in FY 23 and FY 24 and an associated revenue gain to the 
Institutional General Welfare Fund due to redirecting pharmaceutical 
deposits. 
The Out Years 
The annualized ongoing fiscal impact identified above would 
continue into the future subject to inflation.